LC/MS, LC/SQ
IndustriesForensics
ManufacturerAgilent Technologies
Importance of the Topic
In forensic toxicology, reliable detection of opiates and their metabolites in blood is essential to confirm drug use or overdose. The identification of 6-monoacetylmorphine serves as a definitive marker for heroin consumption, while other opiate levels inform medical and legal investigations. Traditional GC/MS methods require derivatization, adding complexity and potential variability, whereas direct electrospray LC/MS offers simplified workflows.
Objectives and Study Overview
This study aimed to develop a robust electrospray LC/MS protocol that quantifies key opiates and metabolites in whole blood without derivatization. Key goals included:
- Establishing a sample preparation workflow compatible with forensic matrices.
- Achieving reliable quantitation over a clinically relevant concentration range.
- Demonstrating comparable or improved performance versus GC/MS-based approaches.
Methodology
Whole blood samples were fortified with target analytes and nalorphine as internal standard, incubated, and buffered at pH 9. Solid phase extraction was performed using C18 SPE cartridges conditioned with methanol, water, and ammonium carbonate buffer. After washing and elution with methanol, extracts were dried under nitrogen, reconstituted in mobile phase, and injected for analysis.
Instrumentation
- LC System: Agilent 1100 Series with binary pump, vacuum degasser, autosampler, thermostatted column compartment, and diode-array detector.
- Column: Supelco Discovery HSC18, 4.6×150 mm, 3 µm.
- Mobile Phase: A = 0.1% formic acid in water; B = methanol; gradient from 5% B to 90% B over 10 min; flow rate 0.5 mL/min; column temperature 50 °C.
- MS Detector: Agilent LC/MSD VL quadrupole with ESI source operating in positive ion scan mode (m/z 100–650); fragmentor 120 V; capillary voltage 3000 V; drying gas 13 L/min at 350 °C; nebulizer 40 psig.
Main Results and Discussion
Recoveries ranged from 85% for 6-acetylmorphine to 100% for morphine, with linear calibration curves (r2 > 0.99) across 0.05–0.75 mg/L. Intra-day precision showed coefficients of variation below 5%, and accuracy within ±5%. Extracted ion chromatograms confirmed clear separation of isobaric pairs. Case studies demonstrated quantitation of morphine, hydromorphone, oxycodone, and codeine in authentic positive blood samples.
Benefits and Practical Applications
- Eliminates derivatization, reducing analytical complexity and potential contamination.
- Enables simultaneous qualitative screening and quantitative analysis in a single run.
- Short gradient re-equilibration time boosts sample throughput.
- Applicable to routine forensic and clinical toxicology workflows.
Future Trends and Potential Applications
- Extension to glucuronide conjugate analysis via enzymatic hydrolysis.
- Lowering limits of quantitation to sub-10 ng/mL levels.
- Integration into high-throughput, multi-analyte screening platforms.
- Application to other drug classes within a unified LC/MS method.
Conclusion
Electrospray LC/MS provides a reliable, accurate, and efficient approach for the determination of opiates and metabolites in whole blood. The method’s simplicity and performance compare favorably with traditional GC/MS techniques, making it well suited for forensic toxicology applications.
References
- Broussard LA, Presley LC, Pittman T, Clouette R, Wimbish GH. Simultaneous identification and quantitation of codeine, morphine, hydrocodone, and hydromorphone in urine as trimethylsilyl and oxime derivatives by gas chromatography–mass spectrometry. Clin Chem. 1997;43:1029–1032.
- Slawson MH, Crouch DJ, Andrenyak DM, Rollins DE, Lu JK, Bailey PL. Determination of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in plasma after intravenous and intrathecal morphine administration using HPLC with electrospray ionization and tandem mass spectrometry. J Anal Toxicol. 1999;23:468–473.
- Schlueter SA, Hutchison JD Jr. Determination of opiates and metabolites in blood using electrospray LC/MS: Application Note for Forensic Toxicology. Agilent Technologies; 2005.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.